A M. Den Boer-Stevense
Breda, NB 4818CK, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/nivolumab in poor prognostic advanced melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 10, 2025
Efficacy of encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the Dutch Melanoma Treatment Registry.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 28, 2025
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.
Journal: British journal of cancer
Published: January 13, 2025
Corrigendum to "Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry" [Eur. J. Cancer 212, 2024, 115056].
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 28, 2024
Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy.
Journal: British journal of cancer
Published: October 04, 2024
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients.
Journal: Cancers
Published: June 28, 2024
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 21, 2024
ONCOR: design of the Dutch cardio-oncology registry.
Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Published: October 20, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026